ADHESION MOLECULE EXPRESSION DURING NEUTROPHIL CHEMOTAXIS
中性粒细胞趋化过程中粘附分子的表达
基本信息
- 批准号:5200847
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The goal of this project is to determine whether human neutrophil (PMN)
surface antigen expression is altered after PMN have migrated towards an
inflammatory stimulus. We have previously shown that PMN adhesion
molecule expression is differentially downregulated after PMN chemotaxis.
The present study was undertaken to examine the changes that occur in PMN
surface molecule expression of aminopeptidase N (CD13) and the Fcg
receptors, FcRII (CD32) and FcRIII (CD16), after PMN chemotaxis in vitro.
Two populations of PMN are easily identified and separated with an in
vitro polycarbonate membrane chemotaxis system; one population does not
migrate towards chemoattractant (nonmigrating population) and remains on
the upper surface of the membrane, whereas the other population migrates
through the membrane pores to the lower surface of the membrane
(migrating population). PMN, incubated in suspension with or without the
N-formyl peptide chemoattractant (FMLP), were compared with the migrating
and nonmigrating subpopulations which were exposed to a gradient of FMLP.
PMN were stained with a panel of monoclonal antibodies which recognize
aminopeptidase N (CD13), or the Fcg receptors, FcRII (CD32) and FcRIII
(CD16), and surface expression was quantified with a flow cytometer.
CD13 expression was not significantly altered after PMN chemotaxis. CD13
expression on migrating and non-migrating PMN populations was equivalent.
In contrast, FcRII and FcRIII expression was down- regulated on the
migrating PMN subpopulation by 42% and 58%, respectively, when compared
with the non- migrating PMN subpopulation. Down-regulation of CD32 did
not occur when non-adherent PMN were stimulated with chemoattractant in
suspension, however, CD16 expression was down-regulated by 42% when
non-adherent PMN were stimulated with FMLP in suspension.
The results of this study demonstrate that PMN surface molecule
expression is selectively down-regulated after PMN chemotaxis. This
experimental system provides a means for quantifying the expression of
myeloid antigens which are important in inflammatory responses.
本项目的目标是确定人类中性粒细胞(PMN)
当中性粒细胞向中性粒细胞表面迁移后,
炎症刺激。 我们之前已经证明,
PMN趋化后分子表达差异下调。
本研究的目的是探讨中性粒细胞的变化,
氨基肽酶N(CD 13)和Fcg的表面分子表达
受体,FcRII(CD 32)和FcRIII(CD 16),在体外PMN趋化后。
两个群体的中性粒细胞很容易识别和分离,
体外聚碳酸酯膜趋化系统;一个群体不
向化学引诱物迁移(非迁移种群)并保持在
膜的上表面,而其他种群则迁移
通过膜孔到达膜的下表面
(流动人口)。 PMN,在有或没有
N-甲酰肽化学引诱物(FMLP)与迁移性
和非迁移亚群,暴露于梯度的FMLP。
PMN用一组单克隆抗体染色,
氨肽酶N(CD 13)或Fcg受体FcRII(CD 32)和FcRIII
(CD 16),并用流式细胞仪定量表面表达。
PMN趋化后CD 13表达无明显改变。 CD13
迁移性和非迁移性中性粒细胞群的表达是相等的。
相反,FcRII和FcRIII的表达下调,
迁移性PMN亚群分别减少42%和58%,
非迁移性中性粒细胞亚群。 CD 32的下调
当非粘附的PMN被化学引诱物刺激时,
然而,在悬浮液中,CD 16表达下调42%,
用悬浮的FMLP刺激非粘附的PMN。
本研究结果表明,PMN表面分子
表达在PMN趋化后选择性下调。 这
实验系统提供了一种用于定量表达
在炎症反应中重要的髓样抗原。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
L HARVATH其他文献
L HARVATH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('L HARVATH', 18)}}的其他基金
ROLE OF CD45 IN PHAGOCYTE MOTILITY AND SIGNAL TRANSDUCTION
CD45 在吞噬细胞运动和信号转导中的作用
- 批准号:
2569051 - 财政年份:
- 资助金额:
-- - 项目类别:
ROLE OF CD45 IN PHAGOCYTE MOTILITY AND SIGNAL TRANSDUCTION
CD45 在吞噬细胞运动和信号转导中的作用
- 批准号:
3770439 - 财政年份:
- 资助金额:
-- - 项目类别:
BIPHASIC FILAMENTOUS-ACTIN POLYMERIZATION IN ACTIVATED NEUTROPHILS
活化中性粒细胞中的双相丝状肌动蛋白聚合
- 批准号:
3804870 - 财政年份:
- 资助金额:
-- - 项目类别:
LAMIN PEPTIDES STIMULATE HUMAN NEUTROPHIL CHEMOKINESIS
核纤层蛋白肽刺激人类中性粒细胞趋化作用
- 批准号:
3804886 - 财政年份:
- 资助金额:
-- - 项目类别:
CYTOSKELETAL PROTEIN CHANGES IN ACTIVATED NEUTROPHILS
活化中性粒细胞中细胞骨架蛋白的变化
- 批准号:
3811075 - 财政年份:
- 资助金额:
-- - 项目类别:
LAMIN PEPTIDES STIMULATE HUMAN NEUTROPHIL CHEMOKINESIS
核纤层蛋白肽刺激人类中性粒细胞趋化作用
- 批准号:
3792617 - 财政年份:
- 资助金额:
-- - 项目类别:
ROLE OF CD45 IN PHAGOCYTE MOTILITY AND SIGNAL TRANSDUCTION
CD45 在吞噬细胞运动和信号转导中的作用
- 批准号:
6101309 - 财政年份:
- 资助金额:
-- - 项目类别:
LEUCOKYTE COMMON ANTIGEN (CD45) IS INVOLVED IN NEUTROPHIL CHEMOTAXIS
白细胞共同抗原 (CD45) 参与中性粒细胞趋化作用
- 批准号:
3811073 - 财政年份:
- 资助金额:
-- - 项目类别:
ROLE OF CD45 IN PHAGOCYTE MOTILITY AND SIGNAL TRANSDUCTION
CD45 在吞噬细胞运动和信号转导中的作用
- 批准号:
6161367 - 财政年份:
- 资助金额:
-- - 项目类别:
ADHESION MOLECULE EXPRESSION DURING NEUTROPHIL CHEMOTAXIS
中性粒细胞趋化过程中粘附分子的表达
- 批准号:
3770440 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
- 批准号:
23H02361 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : GNT1124162 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : 1124162 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9300976 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9920805 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8900121 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8225814 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8699511 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8525355 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
- 批准号:
9115537 - 财政年份:1991
- 资助金额:
-- - 项目类别:
Standard Grant














{{item.name}}会员




